Analysis of the role of tumor infiltrating lymphocytes in different malignancies.
Patricia Arboleda Ezcurra(Instituto Nacional de Enfermedades Neoplásicas), Tatiana Vidaurre(The University of Texas MD Anderson Cancer Center), Miluska Castillo(Instituto Nacional de Enfermedades Neoplásicas), Henry Gómez(National Cancer Center), Carlos Castañeda Altamirano(Instituto Nacional de Enfermedades Neoplásicas), Carolina B. López(Institute for Women's Policy Research), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Esperanza Milla(Instituto Nacional de Enfermedades Neoplásicas), Valeria Villegas(Universidad Peruana Cayetano Heredia), Ketty Dolores Cerna(Instituto Nacional de Enfermedades Neoplásicas)
Cited by 0
Related Papers
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
|Journal of Clinical Oncology|2007|483
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
|npj Breast Cancer|2021|282